Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M57.2Revenue $M6.3Net Margin (%)-82.0Altman Z-Score8.0
Enterprise Value $M24.7EPS $-0.2Operating Margin %-136.9Piotroski F-Score3
P/E(ttm)--Beneish M-Score-1.6Pre-tax Margin (%)-82.0Higher ROA y-yY
Price/Book2.310-y EBITDA Growth Rate %-17.9Quick Ratio10.5Cash flow > EarningsN
Price/Sales8.95-y EBITDA Growth Rate %-5.1Current Ratio10.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-18.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-21.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M48.9ROIC % (ttm)-290.7Gross Margin Increase y-yN

Gurus Latest Trades with PRAN

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

PRAN is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


PRAN: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about PRAN:

    News about PRAN:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    1:39 am Prana Biotech reports safety outcomes of the IMAGINE Extension study; 250mg dose of PBT2 was... Jul 01 2015
    Prana Announces Safety Outcomes of Alzheimer’s IMAGINE Extension Trial Jun 30 2015
    Prana Announces Safety Outcomes of Alzheimer’s IMAGINE Extension Trial Jun 30 2015
    European Commission Approves PBT2 Orphan Designation for Huntington’s Disease Jun 01 2015
    European Commission Approves PBT2 Orphan Designation for Huntington’s Disease Jun 01 2015
    European Commission Approves PBT2 Orphan Designation for Huntington’s Disease Jun 01 2015
    PBT2 Recommended for Orphan Designation in Europe Apr 27 2015
    PBT2 Recommended for Orphan Designation in Europe Apr 27 2015
    4 Stocks Under $10 to Trade for Big Breakouts Mar 10 2015
    The Worst-Performing Biotech Stocks Of 2014 Jan 01 2015
    The Lancet Neurology Publishes Prana's Huntington Disease Trial Nov 19 2014
    The Lancet Neurology Publishes Prana's Huntington Disease Trial Nov 19 2014
    Horizon Pharma's Actimmune Gets Orphan Drug Designation Oct 07 2014
    Prana Biotechnology Up on Orphan Drug Status for PBT2 Sep 08 2014
    US STOCKS-S&P 500 ends at record as jobs report eases Fed worries Sep 05 2014
    US STOCKS-S&P 500 ends at record as jobs report eases Fed worries Sep 05 2014
    US STOCKS-Wall St rises as weak payrolls ease Fed worries Sep 05 2014
    US STOCKS-Wall St rises as weak payrolls ease Fed worries Sep 05 2014
    US STOCKS-Wall St flat following weak payrolls report Sep 05 2014
    US STOCKS-Wall St flat following weak payrolls report Sep 05 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK